Shopping Cart
Remove All
Your shopping cart is currently empty
KW-8232
😃Good
Catalog No. T36762Cas No. 217813-15-5
KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].
KW-8232
😃Good
Catalog No. T36762Cas No. 217813-15-5
KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | KW-8232, an orally active anti-osteoporotic agent, reduces the biosynthesis of PGE2 [1]. |
| In vitro | KW-8232 is an anti-osteoporotic agent that reduces PGE2 biosynthesis in mouse osteoblastic cells[1] and exhibits anti-viral activity against SARS-CoV-2 (EC50 ~1.2 μM)[2]. |
| In vivo | KW-8232 (3, 10, 30 mg/kg, p.o.) significantly increases femoral bone mineral density (BMD) in immobilized rat legs and modulates immobilization-induced abnormal bone turnover. At 30 mg/kg, it markedly reduces urinary calcium excretion, pyridinoline, and deoxypyridinoline—markers of bone resorption—in neurectomized rats. KW-8232's inhibition of bone loss may be linked to decreased prostaglandin (PG)-stimulated bone resorption through regulation of PGE2 production[1]. |
| Molecular Weight | 705.27 |
| Formula | C37H41ClN4O6S |
| Cas No. | 217813-15-5 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (177.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 3.3 mg/mL (4.68 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy KW-8232 | purchase KW-8232 | KW-8232 cost | order KW-8232 | KW-8232 chemical structure | KW-8232 in vivo | KW-8232 in vitro | KW-8232 formula | KW-8232 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.